NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL)

RIGHT TO ATTEND AND NOTICE OF ATTENDANCE

Shareholders who wish to attend the AGM in person must:

• be recorded in the share register kept by Euroclear Sweden AB (the Swedish Central Securities Depository), on Monday, April 13, 2026, and
   
• notify the company of their intention to attend the AGM by Wednesday, April 15, 2026, preferably before 4.00 p.m. CEST:

- by post to the address Getinge AB (publ), “Årsstämma 2026”, c/o Euroclear Sweden AB, Box 191, 101 23 Stockholm, Sweden
- by telephone +46 10-335 08 18 (weekdays between 9.00 a.m. – 4.00 p.m. CEST), or 
- via the company’s website, https://www.getinge.com/int/company/corporate-governance/general-meetings/annual-general-meeting-2026/. 

The notice of attendance shall state name, personal or corporate identity number, address, telephone number and email address (if any), and also the number of any of advisors (not more than two). Shareholders who have notified their attendance and wish to attend the AGM in person must show valid identification at the entrance of the meeting venue.

Shareholders who wish to attend the AGM by postal voting must:

• be recorded in the share register kept by Euroclear Sweden AB (the Swedish Central Securities Depository), on Monday, April 13, 2026, and
• no later than Wednesday, April 15, 2026, preferably before 4.00 p.m. CEST, notify the company of their intention to attend the AGM by submitting their postal vote in accordance with the instructions under “Postal voting” below in order for the postal vote to be received by Euroclear Sweden AB no later than that day.

NOMINEE-REGISTERED SHARES

In order to attend the AGM, shareholders with nominee-registered shares should, in addition to give notice of attendance in person or by postal vote, ensure that the shares are owner-registered in the shareholders name to be listed in the share register on the record date, April 13, 2026. Such registration can be temporary (so-called voting right registration), and request for such voting right registration shall be made to the nominee in accordance with the nominee’s routines within the time the nominee decides. Owner-registration completed by the nominee no later than Wednesday, April 15, 2026 will be considered when the share register is produced.

PROXYS, ETC.

Shareholders participating in person or by postal voting represented by proxy must issue a written, signed and dated power of attorney. The power of attorney may not be more than one year old, unless a longer period of validity is stated, although maximum five years. 

Shareholders attending the AGM in person represented by proxy should submit a power of attorney in original by post to Getinge AB (publ), “Årsstämma 2026”, c/o Euroclear Sweden AB, Box 191, 101 23 Stockholm, Sweden in due time before the AGM. 

Power of attorney for shareholders attending by postal voting represented by proxy, shall be attached to the postal voting form by post or by e-mail, if postal voting is made by sending the postal voting form, or be attached to the digital postal vote if postal voting is made via Euroclear Sweden’s portal. 

A proxy form is available at the company and on the company’s website, https://www.getinge.com/int/company/corporate-governance/general-meetings/annual-general-meeting-2026/. 

Representatives of a legal entity shall attach a certified copy of the certificate of registration or similar document of authorization and provide this in the same way as the proxy is provided.

POSTAL VOTING

The shareholders may exercise their right to vote by postal voting before the AGM. The postal voting form is available on the company’s website, https://www.getinge.com/int/company/corporate-governance/general-meetings/annual-general-meeting-2026/. Postal voting only does not require any separate notice of attendance for the AGM.

Postal voting can be made by:

• submitting the original of the completed and signed postal voting form to Getinge AB (publ), “Årsstämma 2026”, c/o Euroclear Sweden AB, P.O. Box 191, 101 23 Stockholm, Sweden, 
• submitting a scanned copy of the completed and signed postal voting form by email to GeneralMeetingServices@euroclear.com (type in “Getinge AB – Postal voting” in the subject matter box); or
• the shareholder giving notification of attendance and submits its postal vote digitally through BankID verification via the link that is available on the company’s website https://www.getinge.com/int/company/corporate-governance/general-meetings/annual-general-meeting-2026/ and https://www.euroclear.com/sweden/generalmeetings/.

The completed postal voting form shall be received by Getinge via Euroclear Sweden no later than Wednesday, April 15, 2026. Electronic postal voting has to be made within the same time. If the shareholder is a legal entity, a certificate of registration or corresponding authorization document shall be enclosed to the postal voting form and if the shareholder is represented by proxy, a power of attorney shall be enclosed to the postal voting form/digital postal vote in accordance with what is described under the heading “Proxys, etc.” above.

The shareholder may not provide the postal voting form with any specific instructions or conditions. If made, the vote (in its entirety) will be deemed invalid. Further instructions and conditions are stated in the postal voting form.

PROPOSAL FOR AGENDA

1. Opening of the Meeting
2. Election of Chairman of the Meeting 
3. Preparation and approval of the voting list
4. Approval of the agenda
5. Election of person(s) to approve the minutes
6. Determination of compliance with the rules of convocation
7. Presentation by the CEO
8. Presentation of work conducted by the Board of Directors and by the Board appointed Remuneration Committee’s, Audit and Risk Committee’s and Ethics and Sustainability Committee’s work and functions
9. Presentation of the Annual Report and the Auditor’s Report and the Consolidated Accounts and the Group Auditor’s Report
10. Resolution regarding adoption of the Income Statement and the Balance Sheet as well as the Consolidated Income Statement and the Consolidated Balance Sheet 
11. Resolution regarding dispositions in respect of the company’s profit according to the adopted Balance Sheet and determination of record date for dividend
12. Resolution regarding discharge from liability for the Board of Directors and the CEO
13. Establishment of 
(a) the number of Board members and deputy members
(b) the number of auditors and deputy auditors
14. Establishment of fees to 
(a) the Board of Directors (including fees for work in Committees), and 
(b) the auditor(s)
15. Election of Board of Directors and Chairman of the Board
(a) re-election of Carl Bennet;
(b) re-election of Johan Bygge;
(c) re-election of Cecilia Daun Wennborg;
(d) re-election of Dan Frohm;
(e) re-election of Johan Malmquist;
(f) re-election of Mattias Perjos;
(g) re-election of Kristian Samuelsson; 
(h) re-election of Ulrika Dellby;
(i) new election of Camilla Sylvest; and
(j) re-election of Johan Malmquist as Chairman of the Board
16. Election of auditor(s)
17. Resolution regarding approval of remuneration report
18. Resolution regarding guidelines for remuneration to Senior Executives
19. Resolution on authorization for the Board of Directors to resolve on repurchase of own shares
20. Closing of the Meeting

PROPOSALS BY THE NOMINATION COMMITTEE (item 2 and 13-16)

The Nomination Committee in respect of the 2026 AGM has comprised the Chairman of the Board Johan Malmquist, the Chairman of the Nomination Committee Carl Bennet (Carl Bennet AB), Jannis Kitsakis (Fjärde AP-fonden), Sophie Larsén (AMF Pension & Fonder) and Anna Strömberg (Carnegie Fonder). 

The Nomination Committee has proposed the following:

Chairman of the AGM (item 2): The Chairman of the Board, Johan Malmquist.

Board of Directors (item 13 (a) and 15 (a)-(j)): The number of Board members elected by the General Meeting shall be nine without deputy members. As Board members, re-election shall be made of Carl Bennet, Johan Bygge, Cecilia Daun Wennborg, Dan Frohm, Johan Malmquist, Mattias Perjos, Kristian Samuelsson and Ulrika Dellby, and new election shall be made of Camilla Sylvest. Malin Persson has declined re-election. Johan Malmquist shall be re-elected as Chairman of the Board. 

Camilla Sylvest, born 1972, holds a Master of Science in Economics and an Executive MBA. She is a Board member of argenx SE. Previously, Camilla has been Executive Vice President for Commercial Strategy and Corporate Affairs for Novo Nordisk A/S, member of the company Board and General Manager for Novo Nordisks’ operations in Denmark, Germany, Southeast Asia and China. She also has previous experience as Board member of Danish Crown A/S and World Diabetes Foundation. Camilla Sylvest holds no shares in Getinge.

Information concerning all members proposed for re-election is available in the proposal for resolution and motivated statement by the Nomination Committee on the company’s website, https://www.getinge.com/int/company/corporate-governance/general-meetings/annual-general-meeting-2026/. 

Board and committee fees (item 14 (a)): Board fees, excluding remuneration for Committee work, shall be paid in a total of SEK 7,107,100 (SEK 6,833,100) of which, SEK 1,785,000 (SEK 1,715,400) to the Chairman, and SEK 760,300 (SEK 731,100) to each of the other Board members elected by the General Meeting who are not employees of the Group. Work in the Audit and Risk Committee shall be compensated with SEK 339,300 (SEK 326,300) to the Chairman and SEK 166,100 (SEK 159,800) to each of the other members. Work in the Remuneration Committee shall be compensated with SEK 169,700 (SEK 163,100) to the Chairman and SEK 122,900 (SEK 118,200) to each of the other members. Work in the Ethics and Sustainability Committee shall be compensated with SEK 169,700 (SEK 163,100) to the Chairman and SEK 122,900 (SEK 118,200) to each of the other members.

Auditor and auditor fees (item 13 (b), 14 (b) and 16): The number of auditors shall be one with no deputy auditor. The registered auditing company Ernst & Young AB (“EY”) shall be re-elected for the period until the end of the 2027 AGM, in accordance with the recommendation of the Audit and Risk Committee. Fees to the auditor shall be paid in accordance with approved invoices. EY has informed that, should the auditing company be elected, Fredrik Norman will remain the auditor in charge.

THE BOARD OF DIRECTORS’ PROPOSALS 

Disposition of profit and record date for dividend (item 11)

The Board and the CEO have proposed that a dividend of SEK 4.75 per share shall be declared. As record date for the dividend, the Board has proposed Thursday, April 23, 2026. If the AGM resolves in accordance with the proposal, the dividend is expected to be distributed by Euroclear Sweden AB starting Tuesday, April 28, 2026.

Approval of remuneration report (item 17)

The Board of Directors proposes that the AGM resolves to approve the Board’s report over remunerations in accordance with Chapter 8, Section 53 a of the Swedish Companies Act for the financial year 2025.

Resolution regarding guidelines for remuneration to Senior Executives (item 18)

The Board of Directors of Getinge AB (publ) proposes that the 2026 Annual General Meeting resolves on the following guidelines for remuneration to Senior Executives. The currently applicable guidelines for remuneration to Senior Executives were adopted at the 2023 Annual General Meeting. In relation to the currently applicable guidelines, the guidelines that are now proposed for adoption by the 2026 Annual General Meeting mean that the payment of LTI-bonus in exceptional cases, were the nature of the position, the competitive situation and the country of employment so require, may be capped at 50% of the fixed annual base salary. Furthermore, the expectations on Senior Executives’ holdings of Getinge AB shares are being changed and clarified. The proposed amendments also include a changed decision-making process for remuneration in accordance with the guidelines to other Senior Executives (other than the CEO), where the Remuneration Committee is delegated decision-making authority and the introduction of a possibility for the CEO and the Chairman of the Board to, in urgent or extraordinary cases, jointly decide on certain variable remuneration to other Senior Executives in accordance with the dual approval principle. Certain clarifications and editorial changes have also been made. 

No remarks on the remuneration guidelines have emerged in connection with dealings at General Meetings.

1. Scope of the guidelines, etc.

These guidelines cover the individuals who, during the validity period of the guidelines, are included in the group management of Getinge AB (publ), below referred to as “Senior Executives”. The guidelines shall apply to remuneration agreed and amendments in any remunerations already agreed, as of the adoption of the guidelines by the 2026 Annual General Meeting. The guidelines are not applicable on any remuneration resolved by the General Meeting.

2. Promotion of Getinge’s business strategy, long-term interests and sustainability, etc.

A prerequisite for successful implementation of the company’s business strategy and safeguarding the company’s long-term interests is that the company is able to recruit and retain qualified personnel. The main principle is that remuneration and other employment conditions for Senior Executives shall be in line with market terms and competitive on every market where Getinge operates, to ensure that competent and skilled personnel can be attracted, motivated and retained. Individual levels of remuneration shall be based on experience, competence, level of responsibility and performance, and also the country where the Senior Executive is employed. These guidelines promote the company’s business strategy, long-term interests and sustainability as described in the below section regarding criteria for variable remuneration, and contribute to the company’s ability to, on a long-term basis, retain qualified personnel.

For information regarding Getinge’s business strategy, please see the company’s annual reports and the website (https://www.getinge.com).

3. Principles for various types of remuneration, etc.

The total remuneration to Senior Executives shall be in line with market terms and consist of base salary (fixed cash remuneration), any variable cash remuneration and any other variable remuneration, pension benefits and other benefits.

In addition, the General Meeting may – irrespective of these guidelines – resolve on, for instance, share- or share price-related remunerations.

Fixed remuneration

The fixed remuneration, meaning the base salary, shall be based on the individual employee’s area of responsibility, authority, competence, experience and performance.

Variable remuneration

The allocation between base salary and variable remuneration shall be in proportion with the area of responsibility and authority of the executive. The variable remuneration shall always be pre-limited to a maximum amount and related to predetermined and measurable criteria, designed to contribute to the business strategy and long-term added value of the company.

The variable remuneration is designed to promote the company’s strategy to produce and offer products that can support in making health care more efficient in the long-term and to provide better health care for the people who need Getinge’s products. If the above-mentioned activities are performed in an efficient and sustainable way, one outcome is improved financial results and increased capital efficiency, which constitutes the foundation of the variable remuneration. The sustainability work is integrated in the company’s day-to-day operations. If the company’s principles for sustainability or ethical guidelines are not complied with, the company has the possibility to withhold any variable remuneration or reclaim already awarded remuneration.

The variable remuneration may consist of a short-term incentive program (STI) and a long-term incentive program (LTI).

Short-term incentive program (STI) 

The STI may consist of annual variable cash remuneration (STI bonus). For Senior Executives, the STI bonus shall be capped at 70% and, in specific cases, were the nature of the position, the competitive situation and the country of employment so require, capped at 90% of the fixed annual base salary. The STI bonus shall be based on objectives set by the Board of Directors. These objectives shall be related to (i) earnings, (ii) organic sales growth, (iii) working capital, and (iv) sustainability. In order to promote the interest of the shareholders’, the company’s values and collectively strive to achieve the business strategy, long-term interests and sustainable development of the company, all members of the group management shall have the same targets for STI bonus.

Long-term incentive program (LTI): Long-term variable cash remuneration (LTI-bonus)

The LTI may consist of long-term variable cash remuneration (LTI bonus). The target that forms the basis for the LTI-bonus is adjusted earnings per share for a three-year period, adjusted for the category of adjustment items decided by the Board of Directors at implementation of the program, on the recommendation of the Remuneration Committee. By connecting the performance target to the shareholders’ objective, a common interest to promote Getinge’s business strategy, long-term interests and value creation is created. Payment is subject to continued employment at the end of the vesting period for the LTI-bonus (with some customary exceptions).

The vesting period for the LTI-bonus shall be not less than three financial years. The payment of LTI-bonus per each three-year program shall be capped at 33% of one year’s base salary or, in exceptional cases were the nature of the position, the competitive situation and the country of employment so require, at 50% of the fixed annual base salary. A new LTI program can be set up every year with a duration period of three years.

Senior Executives’ holdings of Getinge shares

Senior Executives of the group management are expected to acquire Getinge shares corresponding to at least one year’s salary (gross), calculated based on the share price prevailing from time to time, and maintain the holding for the duration of their employment. To ensure that this objective is acheived, Senior Executivces who have not reached this holding shall invest not less than 50% of each received LTI-bonus (net, after taxes paid) in Getinge shares. The calculation of the total holding includes all shares acquired by the Senior Executive themselves, regardless of when or how they were acquired.

Limitation of total variable remuneration for the CEO

For the CEO, the total payment of variable remuneration (STI bonus and LTI bonus) shall, in addition to what is previously stated, annually be limited so that the total variable remuneration does not exceed 100% of the fixed salary.

Determination of result for variable remuneration, etc.

When the measuring period for achievement of the criteria for payment of the variable remuneration has expired, the Board of Directors shall, based on proposal by the Remuneration Committee, establish to which extent the criteria are achieved. In their assessment on whether the criteria are achieved or not, the Board of Directors may, in accordance with proposal by the Remuneration Committee, allow exception from the established targets in the event of significant unforeseen events. The assessment of achievement of the financial targets shall be based on the company’s most recent published financial information, with any adjustments predetermined by the Board of Directors on the recommendation of the Remuneration Committee. Variable payment can be awarded after the expiration of the measuring period (STI bonus) or be subject to postponed payment (LTI-bonus).

Getinge is actively working to ensure that the company is managed in the most sustainable, responsible and efficient way possible, and that applicable legislations and regulations are complied with. Getinge also apply internal rules, including a code of conduct and different group- wide steering documents (policies, instructions and guidelines) within a range of different areas. Variable remuneration shall not be awarded, or can be reclaimed, if the Senior Executive has acted contrary to these rules, principles or the company’s code of conduct. Variable remuneration shall not be awarded if the earnings before tax is negative. The Board of Directors shall also have the possibility to, in accordance with legislation or agreement, in whole or partly, reclaim any wrongly awarded variable remuneration.

Other variable remuneration

Other variable remuneration than STI- and LTI-bonus can be awarded in case of extraordinary circumstances, provided such extraordinary arrangements are only conducted for the purpose of recruiting or retaining Senior Executives in the Executive Management Team. Such remuneration may not exceed an amount corresponding to 100% of the base salary and only be awarded once a year per individual. For resolutions on such other variable remuneration to the CEO, the Remuneration Committee is preparatory, and the Board of Directors is decision-making. For resolutions on such other variable remuneration to other Senior Executives than the CEO, the Remuneration Committee is the decision-making body. In urgent cases however – if a resolution by the Remuneration Committee cannot be awaited – the CEO shall be able to make such decisions regarding other Senior Executives jointly with the Chairman of the board in accordance with the dual approval principle, but only if the total amount does not exceed 50 % of the fixed annual base salary. Such decision shall be reported back to the Remuneration Committee as soon as possible.

In addition to the variable remuneration above (STI, LTI and other variable remuneration), resolutions by the general meeting on share- or share price related incentive programs, in accordance with item 3 above, can be made from time to time.

Pension and insurance

The CEO has right to retire from the age of 62 and other Senior Executives has right to retire in accordance with applicable local regulations.

Pension contributions for the CEO shall amount to no more than 40% of the fixed base salary on a defined contribution basis. Variable cash remuneration shall not qualify for pension benefits.

Pension contributions for other Senior Executives shall amount to a maximum of 40%* of the pensionable salary and shall be on a defined contribution basis. Variable remuneration shall not qualify for pension benefits in general, except where mandatory by collective bargaining agreement provisions applicable to the executive. In such case, this shall be considered when creating the total benefit package. In addition to the above, Senior Executives may be covered by an additional health income insurance (sw. sjukinkomstförsäkring).

For employments governed by other than Swedish regulations, pension benefits and other insurances may be duly amended to comply with mandatory rules or established local practice, taking into consideration, to the extent possible, the overall purpose of these guidelines.

Other benefits

Other benefits such as company car, additional medical insurance (sw. sjukvårdsförsäkring) and company health care (sw. företagshälsovård), may be provided to the extent this is considered to be in line with market terms for Senior Executives on similar positions on that local market. The total value of such benefits may not exceed 10% of the fixed base salary.

Conditions for termination

Senior Executives shall have a permanent employment. If the company terminates the employment, the notice period shall not exceed twelve months. Upon termination of employment, the total of the fixed salary during the notice period together with severance pay may not exceed an amount equivalent to two years fixed base salary for the CEO, and one years fixed base salary for other executives. If the executive terminates the employment, the notice period shall not exceed six months and be without any right to severance pay.

Senior Executives may be entitled to compensation for any competition restrictions after the termination of employment, however, only to the extent severance pay for the corresponding period is not awarded. The purpose of such compensation is to compensate the executive for any gap between the monthly base salary at the notice of termination and (lower) monthly income received, or that could be received, by a new employment, assignment or own business. The compensation can be awarded during the period of the competition restriction, however, not more than for 12 months after the termination of employment.

Salary and employment conditions for employees

When preparing the Board of Director’s proposal for these remuneration guidelines, salary and employment conditions for the company’s employees have been considered, by including information of the total income of the employees, the components of the remuneration and the increase and growth rate over time as part of the Remuneration Committee’s and the Board of Directors’ basis for decision when evaluating whether the guidelines and the limitations set out herein are reasonable. The development of the gap between the remuneration to Senior Executives and remuneration to other employees will be disclosed in the remuneration report.

4. The resolution process to determine, review and implement the guidelines

The Board of Directors has established a Remuneration Committee. The Committee’s tasks include preparing the Board of Directors’ decision to propose guidelines for Senior Executive remuneration. These are reviewed annually, and the Board shall draft new proposals for guidelines at least every fourth year, which shall be presented to the Annual General Meeting for resolution. The guidelines shall be in force until new guidelines are adopted by the Annual General Meeting. 

The Remuneration Committee shall also monitor and evaluate programs for variable remuneration to Senior Executives, the application of the guidelines for remuneration to Senior Executives, as well as the current remuneration structures and compensation levels in the company, and provide recommendations to the Board of Directors for resolutions on remuneration to the CEO. Regarding resolution on remuneration to other Senior Executives in accordance with the guidelines (other than the specifically regulated above regarding other variable remuneration in case of extraordinary circumstances) resolutions shall be made by the Remuneration Committee.

The CEO and other members of the group management do not participate in the Board of Directors’ or the Remuneration Committees’ processing of, and resolutions on, remuneration-related matters when such matters concern them.

The Board of Directors shall annually draw up a remuneration report that shall be presented to the Annual General Meeting for approval.

5. Deviations from the guidelines

The Board of Directors may temporarily resolve to deviate from the guidelines, entirely or partly, if in a specific case there is special cause for the deviation and a deviation is necessary to serve the company’s long-term interests, a sustainable development of the company or to ensure the company’s financial viability. As set out above, the Remuneration Committee’s tasks include preparing the Board of Directors’ resolutions in remuneration-related matters. This includes any resolutions to deviate from the guidelines.

6. Other

Information regarding remuneration, etc. to Senior Executives during the financial year 2025 is set out in note 22 of the Annual Report 2025, including any previously resolved remuneration that has not yet become due for payment, and in the remuneration report.

Authorization for the Board of Directors to resolve on repurchase of own shares (item 19)

The Board of Directors proposes that the AGM resolves to authorize the Board of Directors to resolve on repurchase of the company’s own Class B shares in accordance with the following terms: i) repurchase of shares may take place on Nasdaq Stockholm; ii) repurchase of shares may take place on one or several occasions during the time up to the 2027 AGM; iii) repurchase of shares may only be made so that the shares held by the company at any point in time does not exceed ten (10) percent of all shares in the company; iv) repurchase of shares shall not be made at a price lower than the lowest price at which an independent acquisition can be made, or at a price higher than the higher of the price of the last independent trade and the highest current independent purchase bid on the trading venue where the purchase is carried out; v) payment for repurchased shares shall be made in cash; and vi) the Board of Directors should be authorized to decide upon any additional terms for the repurchase.

The purpose of the proposed authorization is to give the Board of Directors increased flexibility and possibility to continuously adapt the company’s capital structure and thereby contribute to increased shareholder value.

A decision by the AGM on the proposal according to this item must be supported by shareholders representing at least two thirds of the votes cast as well as the shares present at the AGM in order to be valid.

QUESTIONS AND SHAREHOLDERS’ RIGHT TO INFORMATION 

The Board of Directors and the CEO shall at the AGM, if any shareholder so requests and the Board of Directors believes that it can be done without significant harm to the company, provide information regarding circumstances that may affect the assessment of an item on the agenda, circumstances that can affect the assessment of the company’s or its subsidiaries’ financial position and the company’s relation to other companies within the group.

DOCUMENTS AND OTHER INFORMATION

The Nomination Committee’s complete proposal, information concerning proposed members, reasoned statement on the proposed Board of Directors, and report on the work of the Nomination Committee are available on the company’s website, https://www.getinge.com/int/company/corporate-governance/general-meetings/annual-general-meeting-2026/.

Financial statements and Auditor’s Report, Sustainability Report, Corporate Governance Report and the Board of Directors’ remuneration report for the financial year 2025, will be available at the company and on the company’s website in connection with the publishing of the company’s Annual Report on Thursday, March 26, 2026. 

The statement by the Board of Directors on the proposed distribution of dividend (item 11), the Board of Directors’ complete proposal for authorization on repurchase of own shares and the statement by the Board of Directors pursuant to Chapter 19, Section 22 of the Swedish Companies Act (item 19) and the Auditors statement pursuant to Chapter 8, Section 54 of the Swedish Companies Act regarding guidelines for remuneration to Senior Executives will be available at the company and on the company’s website, no later than on Tuesday, March 31, 2026. Complete versions of all other proposals are available under each item in this notice. 

The documents will be available at the company and on the company’s website, and will be sent to shareholders, who have stated their address, upon request. Copies will also be available at the AGM.

NUMBER OF SHARES AND VOTES IN THE COMPANY

As at the date of this notice, the total number of shares in the company amounts to 272,369,573, whereof 18,217,200 shares of series A and 254,152,373 shares of series B. The total number of votes in the company amounts to 436,324,373. The company holds no own shares.

PROCESSING OF PERSONAL DATA

For information about the processing of your personal data, see https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf. 

If you have questions regarding our processing of your personal data, you can contact the company by email, data.protection@getinge.com. Getinge AB (publ) has corporate ID No. 556408-5032 and the Board of Directors’ registered office is in Gothenburg.

————————————

Gothenburg in March 2026

The Board of Directors of Getinge AB (publ)

* Pension contributions may, exceptionally, exceed this limit if required to comply with mandatory law, collective bargaining agreements or other applicable rules or established local practice, taking into consideration, to the extent possible, the overall purpose of these guidelines.

Contact:
David Kördel, Head of Investor Relations
Phone: +46 (0)10 335 0077
Email: david.kordel@getinge.com

For matters relating to notice to attend, proxy, voting etc., please contact:

Maria Dahlqvist, Head of Corporate Legal, Corporate Secretary
Telephone: +46(0)10 335 00 09
E-mail: maria.dahlqvist@getinge.com

About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.